Judith Graham, a contributing columnist, writes the “Navigating Aging” column for KHN. She has covered health care for more than 30 years. She’s been an investigative reporter, national correspondent and senior health reporter at the Chicago Tribune and a regular contributor to The New York Times’ New Old Age blog. Judith was the first topic leader on aging for the Association of Health Care Journalists. Her work has appeared in publications including Stat News, The Washington Post, and the Journal of the American Medical Association. She is a graduate of Harvard College and has a master’s in journalism from Columbia University.
Paxlovid, an antiviral treatment for people at high risk of severe disease who have mild to moderate cases of COVID-19, is effective against the latest COVID-19 variant. Experts recommend that people at high risk figure out how to access the drug and any effect it may have on their current medications before they contract COVID.